Nancy Lin, MD

@nlinmd

Breast cancer specialist @DanaFarber; Director, EMBRACE MBC program. Tweets are my own and not medical advice.

Joined December 2016

393 Following 3.6K Followers 688 Posts

Latest posts 5

Yes! Pts w/MBC need:

-HER2+: effective tx post TDXD esp that treat/prevent brain mets

TNBC: effective tx post Trop2 x topo1 ADC. ADC are “better chemo” but we need game changers that transform the tail of the OS curve

ER+: options after 1L chemo when OS really starts to fall

Dr Sarah Sammons Verified account @drsarahsam Sep 24

Our immense desire to move every successful therapy in metastatic breast cancer to front line is stifling innovation. Also the “me too” mentality of every company buying the same drug is a challenge.

Hi from the clinic,
We need new targets, new payloads, new 2L and 3L options in TNBC and HeR2+ MBC!
View quoted post on X

Nancy Lin, MD @nlinmd Sep 22

I have really enjoyed working with Wassim on novel liquid biopsy technologies!

Wassim Daoud Khatoun @WDKhatoun Sep 22

Hi #MedTwitter!

Excited to be applying to #InternalMedicine for #Match2027! 🩺

I’m a @lebamericanuni #IMG from 🇱🇧, currently a research fellow studying cancer epigenomics & liquid biopsy @DanaFarber @harvardmed.

AAMC ID: 14999066

Grateful for everyone who made this possible!

View quoted post on X

Nancy Lin, MD @nlinmd Sep 19

Very cool approach leveraging LLM to characterize toxicity and correlate with GWAS at a scale that allows discovery of novel associations!

Sasha Gusev Verified account @SashaGusevPosts Sep 18

Tour de force characterizing therapy toxicity in cancer at very large scale!
View quoted post on X

Nancy Lin, MD @nlinmd Aug 14

Brilliant keynote from @HendriksLizza - ‘Breaking Barriers, Redefining Brain Metastases Treatment Concepts” at #snoasco2026

-identifying pts at high risk
-optimizing tx and sequencing
-access- trials, molecular testing, drugs, knowledge
-multiD teamwork and collaborations

Nancy Lin, MD @nlinmd Aug 8

Such a beautiful story.

Gleevec made the impossible possible. I remember the moment when people with CML no longer filled our bone marrow transplant units, because a small pill transformed their lives.

The power of science + humanity + clinical trials. ❤️🙏

Mel Mann, MBA, M.Ed Verified account @MelDMann Aug 8

31 years ago I was diagnosed with terminal #cancer.

No cure. Three years to live. I recruited many thousands of potential bone marrow donors, but never found one for myself.

My daughter was 5 years old when I was diagnosed. Because of a miracle, I was able to see her grow up, go to #Harvard & become a board certified physician.

In 2015 I shared my clinical trial miracle story. That one post hit 7 million impressions.

I’m still here. The World’s longest-living #Gleevec survivor. Clinical trials rewrote my ending.

Original post:
x.com/MelDMann/statu…
Share if you know someone who needs this hope today! ❤️
#CML #ClinicalTrials #CancerSurvivor

View quoted post on X